Cargando…
TRIP-1 via AKT modulation drives lung fibroblast/myofibroblast trans-differentiation
BACKGROUND: Myofibroblasts are the critical effector cells in the pathogenesis of pulmonary fibrosis which carries a high degree of morbidity and mortality. We have previously identified Type II TGFβ receptor interacting protein 1 (TRIP-1), through proteomic analysis, as a key regulator of collagen...
Autores principales: | Nyp, Michael F, Navarro, Angels, Rezaiekhaligh, Mohammad H, Perez, Ricardo E, Mabry, Sherry M, Ekekezie, Ikechukwu I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946032/ https://www.ncbi.nlm.nih.gov/pubmed/24528651 http://dx.doi.org/10.1186/1465-9921-15-19 |
Ejemplares similares
-
Lung epithelial‐specific TRIP‐1 overexpression maintains epithelial integrity during hyperoxia exposure
por: Nyp, Michael F., et al.
Publicado: (2018) -
Altered Pulmonary Lymphatic Development in Infants with Chronic Lung Disease
por: McNellis, Emily M., et al.
Publicado: (2014) -
Silencing of UTX Mitigates Aging-Associated Cardiac Fibrosis via Blocking Cardiac Fibroblasts-to-Myofibroblasts Trans-Differentiation
por: Li, Chao, et al.
Publicado: (2023) -
Angiotensin-II Drives Human Satellite Cells Toward Hypertrophy and Myofibroblast Trans-Differentiation by Two Independent Pathways
por: Laurino, Annunziatina, et al.
Publicado: (2019) -
Fibroblasts, myofibroblasts, and wound contraction
Publicado: (1994)